GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's cash flow for dividends for the three months ended in Mar. 2016 was $-1,366 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2016 was $-6,189 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
GlaxoSmithKline PLC's quarterly payment of dividends declined from Sep. 2015 ($-1,495 Mil) to Dec. 2015 ($-1,334 Mil) but then increased from Dec. 2015 ($-1,334 Mil) to Mar. 2016 ($-1,366 Mil).
GlaxoSmithKline PLC's annual payment of dividends increased from Dec. 2013 ($-6,023 Mil) to Dec. 2014 ($-6,335 Mil) but then declined from Dec. 2014 ($-6,335 Mil) to Dec. 2015 ($-6,154 Mil).
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
GlaxoSmithKline PLC Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2016 was -1993.7694704 (Jun. 2015 ) + -1495.39877301 (Sep. 2015 ) + -1333.83233533 (Dec. 2015 ) + -1366.0968661 (Mar. 2016 ) = $-6,189 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data